You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-receptor de interleukin 5

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Trial in Qingdao (VDJ001, Placebo)

Completed
  • Healthy
  • Qingdao, Shandong, China
    the Affliated Hospital of Qingdao University
Aug 30, 2023

Clinical Relevance of Small Airways Disease in Severe Asthma

Recruiting
  • Asthma
    • Leeuwarden, Netherlands
      Medical Center Leeuwarden
    Jan 23, 2023

    Idiopathic Multicentric Castleman's Disease Trial in Beijing, Chengdu (Recombinant Humanized Anti-interleukin-6 Receptor

    Recruiting
    • Idiopathic Multicentric Castleman's Disease
    • Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection 4mg/kg
    • +2 more
    • Beijing, China
    • +2 more
    Apr 26, 2022

    Non-Eosinophilic Biological Effects of IL-5

    Not yet recruiting
    • Asthma
      • (no location specified)
      Sep 6, 2023

      Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

      Not yet recruiting
      • Depressive Disorder, Major
      • +2 more
      • New Haven, Connecticut
        Yale University
      Jun 26, 2023

      Clinical Phenotypes in Pericarditis: IL-1RA Antibodies and suPAR

      Not yet recruiting
      • Pericarditis
      • IL1RA Antibody Assay
      • suPAR Testing
      • Homburg, Germany
      • +8 more
      Jun 22, 2023

      Anti-IL-6 Receptor Monoclonal Antibodies on Treatment of

      Recruiting
      • Rheumatoid Arthritis
      • +3 more
        • Barcelona, Spain
          Hospital de la Santa Creu i Sant Pau
        Apr 25, 2022

        Parkinson Disease Trial in Bron, Lyon (neuropsychological assessment, biological sample, medical imagery)

        Not yet recruiting
        • Parkinson Disease
        • neuropsychological assessment
        • +2 more
        • Bron, France
        • +1 more
        Jun 13, 2023

        Moderate to Severe Active Rheumatoid Arthritis Trial in Beijing (HS628+MTX, Actemra +MTX)

        Completed
        • Moderate to Severe Active Rheumatoid Arthritis
        • Beijing, Beijing, China
          Peking Union Medical College Hospital
        Sep 14, 2023

        Psycho-social Impact of Anti-NMDAR Encephalitis

        Not yet recruiting
        • NMDAR Antibody-associated Auto-immune Encephalitis
        • standardized and validated surveys
        • Bron, France
          Centre de référence des syndromes neurologiques paranéoplasiques
        Jul 13, 2023

        Depressive Disorder, Major, Bipolar Disorder, Post Traumatic Stress Disorder Trial in New Haven (Ketamine, Perampanel, Placebo)

        Recruiting
        • Depressive Disorder, Major
        • +2 more
        • New Haven, Connecticut
          Yale University
        Aug 8, 2022

        Clinical Characterization and Outcome of Anti-IgLON5 Disease

        Recruiting
        • Anti-IgLON5 Disease
        • Evaluation of clinical and paraclinical data.
        • Bron, France
          Hospices Civils de Lyon
        Nov 9, 2023

        Primary Mediastinal B-cell Lymphoma, Diffuse, Large B-cell Lymphoma, DLBCL Transformed From Follicular Lymphoma Trial run by the

        Completed
        Has Results
        • Primary Mediastinal B-cell Lymphoma
        • +3 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Dec 29, 2021

        NMDAR Autoimmune Encephalitis, LGI1 Autoimmune Encephalitis Trial in Prague, Praha 5 (Satralizumab, Placebo)

        Not yet recruiting
        • NMDAR Autoimmune Encephalitis
        • LGI1 Autoimmune Encephalitis
        • Prague, Czechia
        • +1 more
        Aug 15, 2022

        Primary Aldosteronism Trial in Montréal (Renin measurements)

        Not yet recruiting
        • Primary Aldosteronism
        • Renin measurements
        • Montréal, Quebec, Canada
          Hôpital du Sacré-Coeur de Montréal
        Oct 30, 2023

        Anti-aging Trial in Rio De Janeiro (Topical serum)

        Completed
        • Anti-aging
        • Topical serum
        • Rio De Janeiro, Brazil
          CIDP Brasil
        Sep 28, 2023

        Axial Spondyloarthritis (axSpA), Ankylosing Spondylitis (AS) Trial in Marseille (blood samples)

        Completed
        • Axial Spondyloarthritis (axSpA)
        • Ankylosing Spondylitis (AS)
        • blood samples
        • Marseille, France
          Assistance Publique Hopitaux de Marseille
        Aug 31, 2022

        Multiple Myeloma, Allogeneic Stem Cell Transplantation Trial in Spain (CARTemis-1)

        Not yet recruiting
        • Multiple Myeloma
        • Allogeneic Stem Cell Transplantation
        • CARTemis-1
        • Santander, Cantabria, Spain
        • +4 more
        Aug 1, 2023

        Glioblastoma Trial in Worldwide (RO7428731)

        Recruiting
        • Glioblastoma
        • Melbourne, Victoria, Australia
        • +4 more
        Aug 2, 2022

        CAR T-Cell Therapy Trial in Shenzhen (HEC-016(0.5×10^6 CAR-T Cells), HEC-016(0.5×10^6.5 CAR-T Cells), HEC-016(0.5×10^7 CAR-T

        Recruiting
        • CAR T-Cell Therapy
        • HEC-016(0.5×10^6 CAR-T Cells)
        • +2 more
        • Shenzhen, Guangdong, China
          Shenzhen Luohu Hospital
        Mar 3, 2022

        Acute Respiratory Distress Syndrome Trial in Montréal (Placebo, Ondansetron Injection)

        Not yet recruiting
        • Acute Respiratory Distress Syndrome
        • Placebo
        • Ondansetron Injection
        • Montréal, Quebec, Canada
          Hôpital Sacré-Coeur de Montréal
        Aug 22, 2022

        Small Cell Lung Cancer and Breast Cancer Trial in Worldwide (Satoreotide tetraxetan, Satoreotide trizoxetan)

        Terminated
        Has Results
        • Small Cell Lung Cancer and Breast Cancer
        • Satoreotide tetraxetan
        • Satoreotide trizoxetan
        • Houston, Texas
        • +7 more
        Aug 22, 2022

        Relapsed/Refractory Multiple Myeloma, Plasma Cell Leukemia Trial (CAR-T (CAR-GPRC5D))

        Not yet recruiting
        • Relapsed/Refractory Multiple Myeloma
        • Plasma Cell Leukemia
        • CAR-T (CAR-GPRC5D)
        • (no location specified)
        Feb 26, 2023

        Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Spain (ARI0003)

        Not yet recruiting
        • Refractory Non-Hodgkin Lymphoma
        • Relapsed Non-Hodgkin Lymphoma
        • ARI0003
        • Santiago De Compostela, A Coruña, Spain
        • +6 more
        Oct 24, 2023

        Sarcoma, Synovial, Sarcoma,Soft Tissue, Melanoma Stage IV Trial in Jerusalem (CYCLOPHOSPHAMIDE and FLUDARABIN, Cyclophosphamide,

        Recruiting
        • Sarcoma, Synovial
        • +8 more
        • CYCLOPHOSPHAMIDE and FLUDARABIN
        • +3 more
        • Jerusalem, Israel
          Hadassah Medical Organization
        Mar 15, 2022